Cephalon appoints Dr Charles Homcy to board
This article was originally published in Scrip
Executive Summary
Cephalon has appointed Dr Charles Homcy to its board of directors. He is a venture partner at Third Rock Ventures and co-chairman of Portola Pharmaceuticals, a privately held biotech firm for which he served as president and chief executive officer from 2003-10.